BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27426130)

  • 1. Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer Therapy.
    Zheng YC; Ma JL; Liu Y; Liu HM
    Curr Pharm Des; 2016; 22(39):5943-5947. PubMed ID: 27426130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting histone lysine methylation in cancer.
    McGrath J; Trojer P
    Pharmacol Ther; 2015 Jun; 150():1-22. PubMed ID: 25578037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional coupling between writers, erasers and readers of histone and DNA methylation.
    Torres IO; Fujimori DG
    Curr Opin Struct Biol; 2015 Dec; 35():68-75. PubMed ID: 26496625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease.
    Bhat KP; Ümit Kaniskan H; Jin J; Gozani O
    Nat Rev Drug Discov; 2021 Apr; 20(4):265-286. PubMed ID: 33469207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of histone lysine methylation: structures of methyl writers and erasers.
    Upadhyay AK; Cheng X
    Prog Drug Res; 2011; 67():107-24. PubMed ID: 21141727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Writing, erasing and reading histone lysine methylations.
    Hyun K; Jeon J; Park K; Kim J
    Exp Mol Med; 2017 Apr; 49(4):e324. PubMed ID: 28450737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncoepigenomics: making histone lysine methylation count.
    Decarlo D; Hadden MK
    Eur J Med Chem; 2012 Oct; 56():179-94. PubMed ID: 22975593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine methylation of transcription factors in cancer.
    Han D; Huang M; Wang T; Li Z; Chen Y; Liu C; Lei Z; Chu X
    Cell Death Dis; 2019 Mar; 10(4):290. PubMed ID: 30926778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of chromatin structure via histone post-translational modification and the link to carcinogenesis.
    Thompson LL; Guppy BJ; Sawchuk L; Davie JR; McManus KJ
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):363-76. PubMed ID: 23609752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mind the methyl: methyllysine binding proteins in epigenetic regulation.
    Wagner T; Robaa D; Sippl W; Jung M
    ChemMedChem; 2014 Mar; 9(3):466-83. PubMed ID: 24449612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.
    Wang Z; Patel DJ
    Q Rev Biophys; 2013 Nov; 46(4):349-73. PubMed ID: 23991894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tug of war: adding and removing histone lysine methylation in Arabidopsis.
    Xiao J; Lee US; Wagner D
    Curr Opin Plant Biol; 2016 Dec; 34():41-53. PubMed ID: 27614255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone lysine methylation dynamics: establishment, regulation, and biological impact.
    Black JC; Van Rechem C; Whetstine JR
    Mol Cell; 2012 Nov; 48(4):491-507. PubMed ID: 23200123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy.
    Biswas S; Rao CM
    Eur J Pharmacol; 2018 Oct; 837():8-24. PubMed ID: 30125562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Errors in erasure: links between histone lysine methylation removal and disease.
    Duncan EM; Allis CD
    Prog Drug Res; 2011; 67():69-90. PubMed ID: 21141725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic small molecule modulators of histone and DNA methylation.
    Hauser AT; Robaa D; Jung M
    Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone lysine methylation and chromatin replication.
    Rivera C; Gurard-Levin ZA; Almouzni G; Loyola A
    Biochim Biophys Acta; 2014 Dec; 1839(12):1433-9. PubMed ID: 24686120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LSD1 knockdown reveals novel histone lysine methylation in human breast cancer MCF-7 cells.
    Jin Y; Huo B; Fu X; Cheng Z; Zhu J; Zhang Y; Hao T; Hu X
    Biomed Pharmacother; 2017 Aug; 92():896-904. PubMed ID: 28601046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone modification enzymes: novel targets for cancer drugs.
    Kristeleit R; Stimson L; Workman P; Aherne W
    Expert Opin Emerg Drugs; 2004 May; 9(1):135-54. PubMed ID: 15155140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine Methylation Regulators Moonlighting outside the Epigenome.
    Cornett EM; Ferry L; Defossez PA; Rothbart SB
    Mol Cell; 2019 Sep; 75(6):1092-1101. PubMed ID: 31539507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.